By Dennis Thompson HealthDay Reporter THURSDAY, May 5, 2022 (HealthDay News) — Two experimental vaccines show promise in protecting against infection with the “mono” virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports. Tested only in animals so far, the vaccines block two pathways … Read more
By Amy Norton HealthDay Reporter FRIDAY, Jan. 14, 2022 (HealthDay News) — For years, researchers have suspected that the Epstein-Barr virus, best known for causing mononucleois, might also play a role in triggering multiple sclerosis. Now a new study strengthens the case. The study, of more than 10 million U.S. military personnel, found the risk … Read more
WEDNESDAY, June 30, 2021 (HealthDay News) — Some folks suffering COVID long-haul symptoms might actually be experiencing an attack of fatigue-inducing Epstein-Barr virus (EBV), a new study argues. Two-thirds of a group of 30 COVID long-haul patients had high levels of Epstein-Barr antibodies, suggesting that EBV lying dormant in their bodies had been reactivated … Read more